Thursday, May 05, 2022 9:05:40 PM
https://www.citybiz.co/article/258201/scopus-biopharma-appoints-raphael-hofstein-ph-d-to-its-board-of-directors/
Dr. Hofstein stated, “I am delighted to resume serving on the Board of Scopus. Having founded and nurtured many successful biotech companies, I am extremely excited about the Duet Platform, which encompasses an exceptional and comprehensive portfolio of immuno-oncology assets.”
Recent SCPS News
- Form 1-Z - • Edgar (US Regulatory) • 02/09/2024 10:15:27 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/19/2024 10:15:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 09:16:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 09:01:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 09:00:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/21/2023 09:00:15 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 06/28/2023 09:16:19 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM